ATE210986T1 - Zubereitungen von 1,5-benzodiazepinderivaten mit cck-antagonistischen oder agonistischer wirkung mit enterischem überzug - Google Patents

Zubereitungen von 1,5-benzodiazepinderivaten mit cck-antagonistischen oder agonistischer wirkung mit enterischem überzug

Info

Publication number: ATE210986T1
Authority: AT; Austria
Prior art keywords: enteric coating; preparations; benzodiazepine derivatives; agonist action; cck antagonist
Prior art date: 1994-10-14

Application number

AT95935725T

Other languages

English (en)

Inventor

Elizabeth Ellen Sugg

Original Assignee

Glaxo Wellcome Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-14

Filing date

1995-10-13

Publication date

2002-01-15

1995-10-13 Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc

2002-01-15 Application granted granted Critical

2002-01-15 Publication of ATE210986T1 publication Critical patent/ATE210986T1/de

Links

239000002702 enteric coating Substances 0.000 title abstract 2
238000009505 enteric coating Methods 0.000 title abstract 2
ZVAPWJGRRUHKGP-UHFFFAOYSA-N 1h-1,5-benzodiazepine Chemical class N1C=CC=NC2=CC=CC=C12 ZVAPWJGRRUHKGP-UHFFFAOYSA-N 0.000 title 1
239000000556 agonist Substances 0.000 title 1
239000003754 cholecystokinin receptor blocking agent Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
239000002775 capsule Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000007909 solid dosage form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT95935725T 1994-10-14 1995-10-13 Zubereitungen von 1,5-benzodiazepinderivaten mit cck-antagonistischen oder agonistischer wirkung mit enterischem überzug ATE210986T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9420748A GB9420748D0 (en)	1994-10-14	1994-10-14	1,5 benzodiazepine derivatives
PCT/US1995/012829 WO1996011701A1 (en)	1994-10-14	1995-10-13	Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity

Publications (1)

Publication Number	Publication Date
ATE210986T1 true ATE210986T1 (de)	2002-01-15

Family

ID=10762855

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95935725T ATE210986T1 (de)	1994-10-14	1995-10-13	Zubereitungen von 1,5-benzodiazepinderivaten mit cck-antagonistischen oder agonistischer wirkung mit enterischem überzug

Country Status (11)

Country	Link
EP (1)	EP0785794B1 (de)
JP (1)	JP3907700B2 (de)
AT (1)	ATE210986T1 (de)
AU (1)	AU3763495A (de)
DE (1)	DE69524781T2 (de)
DK (1)	DK0785794T3 (de)
ES (1)	ES2170168T3 (de)
GB (1)	GB9420748D0 (de)
PT (1)	PT785794E (de)
SI (1)	SI0785794T1 (de)
WO (1)	WO1996011701A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6558952B1 (en) *	1992-12-14	2003-05-06	Waratah Pharmaceuticals, Inc.	Treatment for diabetes
JP4530433B2 (ja) *	1996-05-07	2010-08-25	プリヴァ・ディー・ディー	脂質及びグルコースの代謝疾患治療のための方法及び組成物
IL287136B2 (en)	2016-02-05	2023-09-01	Denali Therapeutics Inc	Receptor inhibitors - interacting with protein kinase 1
HUE058802T2 (hu)	2016-12-09	2022-09-28	Denali Therapeutics Inc	RIPK1 inhibitorokként alkalmas vegyületek
US11999750B2 (en)	2022-01-12	2024-06-04	Denali Therapeutics Inc.	Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR890100827A (el) *	1988-12-21	1991-03-15	Abbott Lab	Μέ?οδος παραγωγής παραγώγων τετραπεπτιδίων ως ανταγωνιστών CCK.
GB9201180D0 (en) *	1992-01-21	1992-03-11	Glaxo Group Ltd	Chemical compounds
GB9307833D0 (en) *	1993-04-15	1993-06-02	Glaxo Inc	Modulators of cholecystokinin and gastrin

1994
- 1994-10-14 GB GB9420748A patent/GB9420748D0/en active Pending
1995
- 1995-10-13 WO PCT/US1995/012829 patent/WO1996011701A1/en not_active Ceased
- 1995-10-13 AT AT95935725T patent/ATE210986T1/de not_active IP Right Cessation
- 1995-10-13 EP EP95935725A patent/EP0785794B1/de not_active Expired - Lifetime
- 1995-10-13 PT PT95935725T patent/PT785794E/pt unknown
- 1995-10-13 DE DE69524781T patent/DE69524781T2/de not_active Expired - Fee Related
- 1995-10-13 AU AU37634/95A patent/AU3763495A/en not_active Abandoned
- 1995-10-13 DK DK95935725T patent/DK0785794T3/da active
- 1995-10-13 ES ES95935725T patent/ES2170168T3/es not_active Expired - Lifetime
- 1995-10-13 SI SI9530576T patent/SI0785794T1/xx unknown
- 1995-10-13 JP JP51331396A patent/JP3907700B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU3763495A (en)	1996-05-06
DE69524781T2 (de)	2002-06-20
ES2170168T3 (es)	2002-08-01
EP0785794B1 (de)	2001-12-19
DE69524781D1 (de)	2002-01-31
PT785794E (pt)	2002-06-28
GB9420748D0 (en)	1994-11-30
WO1996011701A1 (en)	1996-04-25
JP3907700B2 (ja)	2007-04-18
SI0785794T1 (en)	2002-08-31
DK0785794T3 (da)	2002-03-18
JPH10511930A (ja)	1998-11-17
EP0785794A1 (de)	1997-07-30

Similar Documents

Publication	Publication Date	Title
EA200200571A1 (ru)	2002-12-26	Новая композиция и ее применение
FI951901L (fi)	1995-04-21	Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus
ATE189400T1 (de)	2000-02-15	Knochenwachstumsfördernde zusammensetzung
ITRM920155A1 (it)	1993-09-06	Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil1h-indol-5-metansolfonammide, relativo procedimento di preparazione e impiego della stessa nel trattamento di mammiferi
RU93004970A (ru)	1997-04-10	Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция
FI942092A7 (fi)	1994-11-11	Hallitusti vapauttava valmiste
SE9504661D0 (sv)	1995-12-22	New compounds
FI970634L (fi)	1997-02-14	Syklosporiinien uudet, suun kautta annettavat, koostumukseltaan yksinkertaiset valmistemuodot, joista biosaatavuus on hyvä, sekä menetelmä niiden valmistamiseksi
EA200200119A1 (ru)	2002-06-27	β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ
FI973691A7 (fi)	1997-09-15	Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäv iä koostumuksia
SE8804628D0 (sv)	1988-12-22	New compounds
ES2062137T3 (es)	1994-12-16	Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
LV10267A (lv)	1994-10-20	Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
IT9019112A1 (it)	1991-07-19	Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
ATE210986T1 (de)	2002-01-15	Zubereitungen von 1,5-benzodiazepinderivaten mit cck-antagonistischen oder agonistischer wirkung mit enterischem überzug
SE9504662D0 (sv)	1995-12-22	New compounds
HUP9702448A2 (hu)	1999-10-28	Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény
MX9709453A (es)	1998-02-28	Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
RU93047049A (ru)	1996-09-20	Новые производные фосфолипидов
NO912497D0 (no)	1991-06-26	Doseringsform for administrering av kalsiumantagonist.
ITMI922969A0 (it)	1992-12-24	Nuovi peptidi sintetici, processo per la loro preparazione, composizioni farmaceutiche che li contengono e loro impiego per la somministrazione di farmaci attraverso la barriera emato-encefalica e la retina.
MX9203581A (es)	1992-07-01	Composiciones farmaceuticas de indolinas 3,3-disubstituidas, para administracion nasal.
IT1157908B (it)	1987-02-18	Nuovo composto farmacologicamente attivo, procedimento per la sua preparazione e relative composizioni farmaceutiche
FR2655344B1 (fr)	1992-04-03	Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant.
ITMI913306A1 (it)	1993-06-10	Composizioni farmaceutiche per la somministrazione nasale di polipeptidi.

Legal Events

Date	Code	Title	Description
2010-07-15	REN	Ceased due to non-payment of the annual fee